Viewing StudyNCT05919069



Ignite Creation Date: 2024-05-06 @ 7:09 PM
Last Modification Date: 2024-10-26 @ 3:01 PM
Study NCT ID: NCT05919069
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-06-11
First Post: 2023-06-16

Brief Title: A Phase I Study to Investigate the Effect of Hepatic Impairment on the PK Safety and Tolerability of AZD2693
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Hepatic Impairment
Keywords:
Name View
Healthy Matches View
Mild View
Moderate View
Severe View